Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah Wordsworth

Showing results (1-10 of 141) with videos related to

Pageof 15
Sort By:
Journal of Public Health Medicine|July 27, 2002
Ultrasound scanning by general practitioners: is it worthwhile?Sarah Wordsworth, Anthony Scott
Pharmacoeconomics - Open|October 5, 2018
Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future ResearchJames Buchanan, Sarah Wordsworth
Health Economics|September 24, 2004
Comparing costing results in across country economic evaluations: the use of technology specific purchasing power paritiesSarah Wordsworth, Anne Ludbrook
Health Economics|November 24, 2011
Cost-minimisation analysis versus cost-effectiveness analysis, revisitedHelen Dakin, Sarah Wordsworth
Pharmacoeconomics|February 15, 2015
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?James Buchanan, Sarah Wordsworth
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2015
Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3LPadraig Dixon, Helen Dakin, Sarah Wordsworth
Pharmacoeconomics|November 20, 2019
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic DisordersPatrick Fahr, James Buchanan, Sarah Wordsworth
The Patient|May 12, 2016
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice ExperimentJames Buchanan, Sarah Wordsworth, Anna Schuh
Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna Schuh
Applied Health Economics and Health Policy|April 4, 2019
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision MedicinePatrick Fahr, James Buchanan, Sarah Wordsworth
Pageof 15

Showing results (1-10 of 141) with videos related to

Sort By:
Pageof 15
Journal of Public Health Medicine|July 27, 2002
Ultrasound scanning by general practitioners: is it worthwhile?Sarah Wordsworth, Anthony Scott
Pharmacoeconomics - Open|October 5, 2018
Evaluating the Outcomes Associated with Genomic Sequencing: A Roadmap for Future ResearchJames Buchanan, Sarah Wordsworth
Health Economics|September 24, 2004
Comparing costing results in across country economic evaluations: the use of technology specific purchasing power paritiesSarah Wordsworth, Anne Ludbrook
Health Economics|November 24, 2011
Cost-minimisation analysis versus cost-effectiveness analysis, revisitedHelen Dakin, Sarah Wordsworth
Pharmacoeconomics|February 15, 2015
Welfarism versus extra-welfarism: can the choice of economic evaluation approach impact on the adoption decisions recommended by economic evaluation studies?James Buchanan, Sarah Wordsworth
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|October 15, 2015
Generic and disease-specific estimates of quality of life in macular degeneration: mapping the MacDQoL onto the EQ-5D-3LPadraig Dixon, Helen Dakin, Sarah Wordsworth
Pharmacoeconomics|November 20, 2019
A Review of Health Economic Studies Comparing Traditional and Massively Parallel Sequencing Diagnostic Pathways for Suspected Genetic DisordersPatrick Fahr, James Buchanan, Sarah Wordsworth
The Patient|May 12, 2016
Patients' Preferences for Genomic Diagnostic Testing in Chronic Lymphocytic Leukaemia: A Discrete Choice ExperimentJames Buchanan, Sarah Wordsworth, Anna Schuh
Pharmacogenomics|November 19, 2013
Issues surrounding the health economic evaluation of genomic technologiesJames Buchanan, Sarah Wordsworth, Anna Schuh
Applied Health Economics and Health Policy|April 4, 2019
A Review of the Challenges of Using Biomedical Big Data for Economic Evaluations of Precision MedicinePatrick Fahr, James Buchanan, Sarah Wordsworth
Pageof 15